|
Gene Vaccines9 l, s/ u/ a/ d- e
Thalhamer, Josef; Weiss, Richard; Scheiblhofer, Sandra (Eds.): a( i! u' N$ W- f1 D
1st Edition., 2012, XI, 330 p. 49 illus., 41 in color.( T( G& v i2 c" i" j
9 }+ {* ]( v( o+ I; hHardcover, ISBN 978-3-7091-0438-5+ Y; X k9 S* [! {! `9 M" r
Online orders shipping within 2-3 days( Y t( r5 j& F( m
149,95 # q" L: ?, _7 [; I. E6 j' M& u5 K+ V
0 S. J. E0 [% m) z7 n4 u! X目录
9 G6 v0 F9 b4 K4 W6 n ZPreface.- 1 General mechanisms of gene vaccines.- 2 Strategies to Improve DNA Vaccine Potency: HPV-associated Cervical Cancer as a Model System.- 3 Immune-activating mechanisms of replicase-based DNA and RNA vaccines and their role in immune-apoptosis.- 4 Cytokine genes as molecular adjuvants for DNA vaccines.- 5 Pharmaceutical non-viral formulations for gene vaccines.- 6 Rational design of formulated DNA vaccines: the DermaVir approach.- 7 In vivo electroporation.- 8 Electroporation-based Trigrid™ delivery system (TDS) for DNA vaccine administration.- 9 Prime Boost Regimens for Enhancing Immunity: Magnitude, Quality of Mucosal and Systemic Gene Vaccines.- 10 Intranodal genetic immunization.- 11 Immunotherapy of cancer with RNA vaccines.- 12 DNA and RNA vaccines for prophylactic and therapeutic treatment of type I allergy.- 13 Approved veterinary vaccines – paving the way to products for human use.- 14 Current status of regulations for DNA vaccines.- 15 State of the art production of antibiotic resistance-free plasmid DNA.- 16 Industrial Manufacturing of Plasmid-DNA Products for Gene Vaccination and Therapy.
9 f# e- z4 B/ D C% b5 L
+ Z* b3 x" Z# [$ Y; m! e5 r下载地址:0 ]; T+ B, d0 m
% d" u# }4 k' C" S5 l, E- w9 b8 F$ s& B" ^. j- B
|
|